<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01400243</url>
  </required_header>
  <id_info>
    <org_study_id>NIH/NIDA 1R01DA031006 - 01</org_study_id>
    <secondary_id>R01DA031006</secondary_id>
    <nct_id>NCT01400243</nct_id>
  </id_info>
  <brief_title>Nicotine Patch for Marijuana Withdrawal</brief_title>
  <acronym>NMW</acronym>
  <official_title>Nicotine for Marijuana Withdrawal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern Illinois University Carbondale</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Southern Illinois University Carbondale</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this 3-year trial is to test the efficacy of transdermal nicotine patch versus
      placebo patch on marijuana withdrawal symptoms in cannabis-dependent individuals, using a
      randomized, double-blind, and placebo-controlled design. This proposal is in response to
      RFA-DA-10-016(R01) Medications Development for Cannabis-Related Disorders. Consistent with
      the goals of this RFA, the overall goal of the proposed project is to assess the impact of
      transdermal nicotine patch (TNP) on marijuana (MJ) withdrawal (negative affect and craving
      motivated by negative affect) symptoms in MJ-dependent individuals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this proposal is to accurately assess the effects of TNP on MJ withdrawal symptoms
      across 15 days of biochemically confirmed MJ abstinence using a placebo-controlled,
      double-blind, randomly assigned treatment design, while closely monitoring any potential
      adverse effects, including changes in nicotine use and dependence.

      To achieve these goals, 116 carefully screened cannabis-dependent individuals (58 female)
      will be randomly assigned to one of two doses (0 mg or 7mg nicotine) of TNP (transdermal
      nicotine patch) while they abstain from MJ for 15 days. Subjects will be administered a
      follow-up phone interview 30 days after the termination of treatment to assess the effects of
      nicotine-patch treatment on: 1) frequency of nicotine and tobacco smoking intake, 2)
      Fagerstrom Test of Nicotine Dependence (FTND)-assessed nicotine dependence, 3) new use of
      nicotine during the time since completion of the study, and 4) marijuana and other drug use
      patterns. Large financial contingencies will be used to provide a high degree of abstinence
      and study completion. This will be the first adequately powered study to assess the effects
      of TNP on MJ negative affect-related withdrawal symptoms and urges to use MJ. Withdrawal
      patterns and abstinence will be assessed in two groups of MJ-dependent individuals: 1) those
      who rarely or never smoke tobacco, and 2) those who smoke four or fewer tobacco cigarettes
      per day (very-light tobacco smokers). A stratified randomization method will be used to
      control for gender and tobacco-smoker status. It is hypothesized that MJ withdrawal symptoms
      will be less severe in the group assigned to the 7 mg patch than in the group assigned to the
      placebo. It is also hypothesized that individuals high in anxiety/neuroticism and those high
      in aggression/hostility will exhibit greater benefits from TNP than those low in these
      traits. Given that no gender differences were observed in our preliminary study, gender
      differences are not predicted. The over-the-counter availability, minimal abuse risks, and
      minimal adverse side-effects associated with TNP would make it an ideal and highly
      implementable treatment for MJ dependence if it can be demonstrated to be efficacious in
      reducing MJ withdrawal symptoms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Profile of Mood Scale Total Negative Affect (Tension + Depression + Anger)</measure>
    <time_frame>16 days (prequit baseline and 15 days of abstinence)</time_frame>
    <description>POMS Total negative affect was assessed during the final pre-quit baseline session and the 8 post-quit sessions (1, 3, 5, 7, 9, 11, 13, and 15 days post-quit). The Total negative affect score has a minimum potential value of &quot;0&quot; = best possibly level and a maximum value of &quot;154&quot; = worst possible level.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Marijuana Withdrawal Questionnaire (MWC) Total Score</measure>
    <time_frame>16 days (prequit baseline and at 1, 3, 5, 7, 9, 11, 13, and 15 days of abstinence)</time_frame>
    <description>The Marijuana Withdrawal Questionnaire Total Score includes items assessing anxiety, depression, irritability, appetite, aggression/anger, sleep disturbance, somatic disturbances, and craving to use marijuana. The potential range of this total score is from &quot;0&quot; = no withdrawal symptoms to &quot;47&quot; = maximally high levels of withdrawal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>POMS Vigor/Positive Affect (PA)</measure>
    <time_frame>16 days (baseline through day 15 of treatment)</time_frame>
    <description>Profile of Mood State questionnaire Vigor/Positive Affect scale. The potential range of the Vigor/Positive Affect scale is from &quot;0&quot; (no vigor) to &quot;32&quot; (maximally high vigor score).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patch Guess and Attributions Questionnaire</measure>
    <time_frame>Day 15 of abstinence</time_frame>
    <description>The Patch Guess and Attributions Questionnaire assesses which type of patch (active versus placebo) the subject believes that he or she was given during the study. This assessment was made at end of treatment (Day 15 of abstinence), the last day on a patch. Scores range from 0 percent to 100 percent chance of being on the nicotine patch for those actually on the placebo patch and from 0 percent to 100 percent chance of being on the nicotine patch for those subjects actually on the nicotine patch. Each subject was asked to indicate the percentage chance that he or she was on the nicotine (as opposed to the placebo) patch. The mean values reported below are the group mean percentage averages.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure (SBP)</measure>
    <time_frame>From baseline to Day 15 of abstinence</time_frame>
    <description>Systolic blood pressure was measured in mmHg during each experimental session prior and subsequent to quitting marijuana.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tobacco and Nicotine Intake</measure>
    <time_frame>Basesline 30 days prior to study and during the 30 days following the 15-day abstinence phase.</time_frame>
    <description>Nicotine intake was assessed by self-reported tobacco cigarettes per month (30 days) at baseline (prior to treatment) and also across the 30 days starting immediately after the end of treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Tetrahydrocannabinol (THC) Concentration in ng/ml.</measure>
    <time_frame>across baseline and at 3, 5, 7, 9, 11, 13, and 15 days of abstinence</time_frame>
    <description>Tetrahydrocannabinol (THC) Intake assessed by assessing urine sample creatinine corrected THC in ng/ml urine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Baseline through Day 15 of abstinence</time_frame>
    <description>Heart rate measured during laboratory assessment sessions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure (DBP)</measure>
    <time_frame>From baseline to Day 15 of abstinence</time_frame>
    <description>Diastolic blood pressure measured during each of the experimental sessions-- baseline through 15-days post-quit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">127</enrollment>
  <condition>Marijuana Dependence</condition>
  <arm_group>
    <arm_group_label>Placebo Patch</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo patch for 15-day quit period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nicotine Patch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>7 mg Habitrol nicotine patch-15 day quit period</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine</intervention_name>
    <description>Nicotine patch 7mg</description>
    <arm_group_label>Nicotine Patch</arm_group_label>
    <other_name>Habitrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Patch</intervention_name>
    <description>Placebo patch</description>
    <arm_group_label>Placebo Patch</arm_group_label>
    <other_name>Placebo patch from Rejuvenations Lab</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Female and male cannabis-dependent MJ smokers aged 18 years or older
        will be recruited. Inclusion criteria include cannabis dependence as assessed by a
        Diagnostic and Statistical Manual (DSM-IV)-based structured interview and MJ use on 10-28
        occasions per week and be willing to abstain for 15 days. Only individuals who are in good
        mental and physical health, with a BMI of 17-30 kg/m2, as verified by health questionnaires
        and the Structured Clinical Interview for DSM-IV (SCID), will participate in this study.
        Potential subjects will be asked to indicate, on a scale of 1-10, how strong they currently
        want to quit smoking MJ (from &quot;1&quot; = &quot;not at all&quot; to &quot;10&quot; = &quot;very strong&quot;) and will also be
        assessed with the four-item MJ Stages of Change. Additionally, subjects will fulfill one of
        two criteria: 1) not smoke or use other tobacco products or 2) smoke tobacco cigarettes or
        use other nicotine delivery systems (e.g., hookah, cigars, chewing tobacco) fewer than 5
        times per day (on average) for the past year. Current use of MJ and tobacco will be
        verified by detectable urine Tetrahydrocannabinol (THC) and nicotine metabolites. All
        subjects will be required to provide four pre-quit baseline urine samples. The mean
        creatinine-normalized THC concentration across these samples must be of 175 ng/ml or
        greater based. -

        Exclusion Criteria:

        Criteria include meeting DSM-IV criteria for current abuse or dependence on a substance
        other than MJ, nicotine, or caffeine, using psychoactive substances (other than MJ,
        alcohol, nicotine, &amp; caffeine) 6+ times/month, testing positive for stimulants,
        antidepressants, anxiolytics, and/or opiates (10-panel urine drug test), testing above a
        salivary cotinine concentration of 150 ng/ml during the initial screening, using creatinine
        or creatinine-containing supplements, testing positive for adulteration of urine samples,
        consuming more than 6 alcoholic drinks per day continuously for a month, mental disorders
        including bipolar disorder, schizophrenia, psychotic symptoms, currently, recently, or ever
        chronically at significant suicidal risk or experiencing violent thoughts or current major
        depression. Others that will be excluded include women who are pregnant, lactating, not
        taking precautions to avoid pregnancy, individuals with significant physical disorders or
        unstable physical disorders that may represent a severe untreated condition, such as
        hypertension, as well as those with less than a high school education or equivalent,
        primary language other than English, and those with significant cognitive impairment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David G Gilbert, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern Illinois University Carbondale</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southern Illinois University</name>
      <address>
        <city>Carbondale</city>
        <state>Illinois</state>
        <zip>62901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2011</study_first_submitted>
  <study_first_submitted_qc>July 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2011</study_first_posted>
  <results_first_submitted>February 20, 2015</results_first_submitted>
  <results_first_submitted_qc>April 16, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 30, 2015</results_first_posted>
  <last_update_submitted>April 16, 2015</last_update_submitted>
  <last_update_submitted_qc>April 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Marijuana</keyword>
  <keyword>Drug withdrawal symptoms</keyword>
  <keyword>Nicotine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Female and male cannabis-dependent individuals 18 years or older were recruited by flyers and advertisements in newspapers to participate in the study in the locally well-know Southern Illinois University Integrative Neuroscience Laboratory and Smoking Lab.</recruitment_details>
      <pre_assignment_details>During four sessions across three weeks prior to quitting the use of marijuana, subjects completed questionnaires that assessed mood, drug use, urge to use marijuana (MJ), questionnaires, and motivation to quit MJ, and provided urine, saliva, and expired breath samples for the level of marijuana and other drug use level.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo Patch</title>
          <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
        </group>
        <group group_id="P2">
          <title>Nicotine Patch</title>
          <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo Patch</title>
          <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
        </group>
        <group group_id="B2">
          <title>Nicotine Patch</title>
          <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="64"/>
            <count group_id="B2" value="63"/>
            <count group_id="B3" value="127"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.57" spread="2.43"/>
                    <measurement group_id="B2" value="21.19" spread="3.86"/>
                    <measurement group_id="B3" value="20.87" spread="3.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Profile of Mood Scale Total Negative Affect (Tension + Depression + Anger)</title>
        <description>POMS Total negative affect was assessed during the final pre-quit baseline session and the 8 post-quit sessions (1, 3, 5, 7, 9, 11, 13, and 15 days post-quit). The Total negative affect score has a minimum potential value of &quot;0&quot; = best possibly level and a maximum value of &quot;154&quot; = worst possible level.</description>
        <time_frame>16 days (prequit baseline and 15 days of abstinence)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Patch</title>
            <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
          </group>
          <group group_id="O2">
            <title>Nicotine Patch</title>
            <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
          </group>
        </group_list>
        <measure>
          <title>Profile of Mood Scale Total Negative Affect (Tension + Depression + Anger)</title>
          <description>POMS Total negative affect was assessed during the final pre-quit baseline session and the 8 post-quit sessions (1, 3, 5, 7, 9, 11, 13, and 15 days post-quit). The Total negative affect score has a minimum potential value of &quot;0&quot; = best possibly level and a maximum value of &quot;154&quot; = worst possible level.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline POMS Total Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.52" spread="1.48"/>
                    <measurement group_id="O2" value="8.096" spread="1.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 1 POMS Total Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.14" spread="1.66"/>
                    <measurement group_id="O2" value="4.615" spread="1.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 3 POMS Total Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.73" spread="1.67"/>
                    <measurement group_id="O2" value="7.48" spread="1.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 5 POMS Total Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.86" spread="1.52"/>
                    <measurement group_id="O2" value="6.62" spread="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 7 POMS Total Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.34" spread="2.45"/>
                    <measurement group_id="O2" value="8.60" spread="2.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 9 POMS Total Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.36" spread="1.74"/>
                    <measurement group_id="O2" value="6.87" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 11 POMS Total Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.30" spread="1.92"/>
                    <measurement group_id="O2" value="7.23" spread="1.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 13 POMS Total Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.66" spread="1.64"/>
                    <measurement group_id="O2" value="5.31" spread="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 15 POMS Total Negative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.61" spread="1.73"/>
                    <measurement group_id="O2" value="5.10" spread="1.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patch Guess and Attributions Questionnaire</title>
        <description>The Patch Guess and Attributions Questionnaire assesses which type of patch (active versus placebo) the subject believes that he or she was given during the study. This assessment was made at end of treatment (Day 15 of abstinence), the last day on a patch. Scores range from 0 percent to 100 percent chance of being on the nicotine patch for those actually on the placebo patch and from 0 percent to 100 percent chance of being on the nicotine patch for those subjects actually on the nicotine patch. Each subject was asked to indicate the percentage chance that he or she was on the nicotine (as opposed to the placebo) patch. The mean values reported below are the group mean percentage averages.</description>
        <time_frame>Day 15 of abstinence</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Patch</title>
            <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
          </group>
          <group group_id="O2">
            <title>Nicotine Patch</title>
            <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
          </group>
        </group_list>
        <measure>
          <title>Patch Guess and Attributions Questionnaire</title>
          <description>The Patch Guess and Attributions Questionnaire assesses which type of patch (active versus placebo) the subject believes that he or she was given during the study. This assessment was made at end of treatment (Day 15 of abstinence), the last day on a patch. Scores range from 0 percent to 100 percent chance of being on the nicotine patch for those actually on the placebo patch and from 0 percent to 100 percent chance of being on the nicotine patch for those subjects actually on the nicotine patch. Each subject was asked to indicate the percentage chance that he or she was on the nicotine (as opposed to the placebo) patch. The mean values reported below are the group mean percentage averages.</description>
          <units>Percentage chance on nicotine patch</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.23" spread="4.23"/>
                    <measurement group_id="O2" value="59.85" spread="3.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systolic Blood Pressure (SBP)</title>
        <description>Systolic blood pressure was measured in mmHg during each experimental session prior and subsequent to quitting marijuana.</description>
        <time_frame>From baseline to Day 15 of abstinence</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patch</title>
            <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patch</title>
            <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure (SBP)</title>
          <description>Systolic blood pressure was measured in mmHg during each experimental session prior and subsequent to quitting marijuana.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Quit Baseline SBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115.31" spread="1.72"/>
                    <measurement group_id="O2" value="113.48" spread="1.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quit-Day 1 SBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="119.42" spread="1.82"/>
                    <measurement group_id="O2" value="115.21" spread="1.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quit-Day 3 SBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.85" spread="1.74"/>
                    <measurement group_id="O2" value="115.00" spread="1.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quit-Day 5 SBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.25" spread="1.82"/>
                    <measurement group_id="O2" value="117.64" spread="1.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quit-Day 7 SBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121.02" spread="1.91"/>
                    <measurement group_id="O2" value="115.77" spread="1.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quit-Day 9 SBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118.50" spread="1.75"/>
                    <measurement group_id="O2" value="116.73" spread="1.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quit-Day 11 SBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.21" spread="1.85"/>
                    <measurement group_id="O2" value="115.80" spread="1.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quit-Day 13 SBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.58" spread="1.68"/>
                    <measurement group_id="O2" value="115.63" spread="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quit-Day 15 SBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.69" spread="1.78"/>
                    <measurement group_id="O2" value="115.07" spread="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tobacco and Nicotine Intake</title>
        <description>Nicotine intake was assessed by self-reported tobacco cigarettes per month (30 days) at baseline (prior to treatment) and also across the 30 days starting immediately after the end of treatment.</description>
        <time_frame>Basesline 30 days prior to study and during the 30 days following the 15-day abstinence phase.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patch</title>
            <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patch</title>
            <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
          </group>
        </group_list>
        <measure>
          <title>Tobacco and Nicotine Intake</title>
          <description>Nicotine intake was assessed by self-reported tobacco cigarettes per month (30 days) at baseline (prior to treatment) and also across the 30 days starting immediately after the end of treatment.</description>
          <units>Cigarettes per 30 days</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Treatment Tobacco/Week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.47" spread="3.28"/>
                    <measurement group_id="O2" value="7.75" spread="3.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Treatment Tobacco/Week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="3.87"/>
                    <measurement group_id="O2" value="6.66" spread="3.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Tetrahydrocannabinol (THC) Concentration in ng/ml.</title>
        <description>Tetrahydrocannabinol (THC) Intake assessed by assessing urine sample creatinine corrected THC in ng/ml urine.</description>
        <time_frame>across baseline and at 3, 5, 7, 9, 11, 13, and 15 days of abstinence</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patch</title>
            <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patch</title>
            <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Tetrahydrocannabinol (THC) Concentration in ng/ml.</title>
          <description>Tetrahydrocannabinol (THC) Intake assessed by assessing urine sample creatinine corrected THC in ng/ml urine.</description>
          <units>ng/ml urine creatinine-corrected THC</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Quit Baseline THC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="343.35" spread="78.40"/>
                    <measurement group_id="O2" value="400.84" spread="75.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 3 THC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.16" spread="20.43"/>
                    <measurement group_id="O2" value="128.49" spread="19.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 5 THC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.02" spread="9.17"/>
                    <measurement group_id="O2" value="73.07" spread="8.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 7 THC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.86" spread="6.28"/>
                    <measurement group_id="O2" value="54.45" spread="6.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 9 THC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.61" spread="4.35"/>
                    <measurement group_id="O2" value="38.25" spread="4.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 11 THC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.27" spread="3.95"/>
                    <measurement group_id="O2" value="33.31" spread="3.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 13 THC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.04" spread="2.94"/>
                    <measurement group_id="O2" value="27.35" spread="2.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 15 THC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.97" spread="2.88"/>
                    <measurement group_id="O2" value="23.70" spread="2.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.05</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate</title>
        <description>Heart rate measured during laboratory assessment sessions.</description>
        <time_frame>Baseline through Day 15 of abstinence</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patch</title>
            <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patch</title>
            <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate</title>
          <description>Heart rate measured during laboratory assessment sessions.</description>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Quit Baseline Heart Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.44" spread="1.47"/>
                    <measurement group_id="O2" value="67.86" spread="1.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 1 Heart Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.54" spread="1.46"/>
                    <measurement group_id="O2" value="65.98" spread="1.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 3 Heart Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.0" spread="1.60"/>
                    <measurement group_id="O2" value="68.80" spread="1.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 5 Heart Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.25" spread="1.71"/>
                    <measurement group_id="O2" value="67.91" spread="1.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 7 Heart Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.04" spread="1.65"/>
                    <measurement group_id="O2" value="67.34" spread="1.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 9 Heart Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.83" spread="1.67"/>
                    <measurement group_id="O2" value="69.36" spread="1.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 11 Heart Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.02" spread="1.84"/>
                    <measurement group_id="O2" value="70.89" spread="1.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 13 Heart Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.42" spread="1.64"/>
                    <measurement group_id="O2" value="69.88" spread="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 15 Heart Rate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.50" spread="1.58"/>
                    <measurement group_id="O2" value="70.64" spread="1.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diastolic Blood Pressure (DBP)</title>
        <description>Diastolic blood pressure measured during each of the experimental sessions-- baseline through 15-days post-quit.</description>
        <time_frame>From baseline to Day 15 of abstinence</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patch</title>
            <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patch</title>
            <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
          </group>
        </group_list>
        <measure>
          <title>Diastolic Blood Pressure (DBP)</title>
          <description>Diastolic blood pressure measured during each of the experimental sessions-- baseline through 15-days post-quit.</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Quit Baseline DBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.06" spread="1.27"/>
                    <measurement group_id="O2" value="68.05" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 1 DBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.94" spread="1.07"/>
                    <measurement group_id="O2" value="68.32" spread="1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 3 DBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.60" spread="1.28"/>
                    <measurement group_id="O2" value="67.88" spread="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 5 DBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.02" spread="1.21"/>
                    <measurement group_id="O2" value="69.46" spread="1.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 7 DBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.62" spread="1.25"/>
                    <measurement group_id="O2" value="68.52" spread="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 9 DBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.54" spread="1.08"/>
                    <measurement group_id="O2" value="69.29" spread="1.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 11 DBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.50" spread="1.17"/>
                    <measurement group_id="O2" value="71.57" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 13 DBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.19" spread="1.21"/>
                    <measurement group_id="O2" value="70.98" spread="1.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 15 DBP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.75" spread="1.32"/>
                    <measurement group_id="O2" value="69.55" spread="1.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Marijuana Withdrawal Questionnaire (MWC) Total Score</title>
        <description>The Marijuana Withdrawal Questionnaire Total Score includes items assessing anxiety, depression, irritability, appetite, aggression/anger, sleep disturbance, somatic disturbances, and craving to use marijuana. The potential range of this total score is from &quot;0&quot; = no withdrawal symptoms to &quot;47&quot; = maximally high levels of withdrawal.</description>
        <time_frame>16 days (prequit baseline and at 1, 3, 5, 7, 9, 11, 13, and 15 days of abstinence)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Patch</title>
            <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
          </group>
          <group group_id="O2">
            <title>Nicotine Patch</title>
            <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
          </group>
        </group_list>
        <measure>
          <title>Marijuana Withdrawal Questionnaire (MWC) Total Score</title>
          <description>The Marijuana Withdrawal Questionnaire Total Score includes items assessing anxiety, depression, irritability, appetite, aggression/anger, sleep disturbance, somatic disturbances, and craving to use marijuana. The potential range of this total score is from &quot;0&quot; = no withdrawal symptoms to &quot;47&quot; = maximally high levels of withdrawal.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Quit Baseline MWC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.29" spread="0.59"/>
                    <measurement group_id="O2" value="3.67" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 1 MWC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.80" spread="0.53"/>
                    <measurement group_id="O2" value="4.35" spread="0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 3 MWC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.16" spread="0.75"/>
                    <measurement group_id="O2" value="7.12" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 5 MWC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.79" spread="0.80"/>
                    <measurement group_id="O2" value="7.02" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 7 MWC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.30" spread="0.84"/>
                    <measurement group_id="O2" value="6.98" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 9 MWC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.64" spread="0.75"/>
                    <measurement group_id="O2" value="6.04" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 11 MWC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.27" spread="0.81"/>
                    <measurement group_id="O2" value="6.56" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 13 MWC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.48" spread="0.76"/>
                    <measurement group_id="O2" value="5.23" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 15 MWC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.11" spread="0.66"/>
                    <measurement group_id="O2" value="5.02" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>POMS Vigor/Positive Affect (PA)</title>
        <description>Profile of Mood State questionnaire Vigor/Positive Affect scale. The potential range of the Vigor/Positive Affect scale is from &quot;0&quot; (no vigor) to &quot;32&quot; (maximally high vigor score).</description>
        <time_frame>16 days (baseline through day 15 of treatment)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patch</title>
            <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patch</title>
            <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
          </group>
        </group_list>
        <measure>
          <title>POMS Vigor/Positive Affect (PA)</title>
          <description>Profile of Mood State questionnaire Vigor/Positive Affect scale. The potential range of the Vigor/Positive Affect scale is from &quot;0&quot; (no vigor) to &quot;32&quot; (maximally high vigor score).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Quit Baseline Vigor/PA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.45" spread="0.82"/>
                    <measurement group_id="O2" value="11.18" spread="0.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 1 Vigor/PA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.97" spread="0.87"/>
                    <measurement group_id="O2" value="10.72" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 3 Vigor/PA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.82" spread="0.86"/>
                    <measurement group_id="O2" value="12.34" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 5 Vigor/PA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.19" spread="0.84"/>
                    <measurement group_id="O2" value="12.35" spread="0.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 7 Vigor/PA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.40" spread="0.90"/>
                    <measurement group_id="O2" value="11.94" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 9 Vigor/PA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.59" spread="0.91"/>
                    <measurement group_id="O2" value="12.52" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 11 Vigor/PA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.51" spread="0.85"/>
                    <measurement group_id="O2" value="11.94" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 13 Vigor/PA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.43" spread="0.85"/>
                    <measurement group_id="O2" value="12.54" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Quit Day 15 Vigor/PA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.37" spread="0.88"/>
                    <measurement group_id="O2" value="12.15" spread="0.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Nicotine Patch</title>
          <description>7 mg Habitrol nicotine patch-15 day quit period
Nicotine: Nicotine patch 7mg</description>
        </group>
        <group group_id="E2">
          <title>Placebo Patch</title>
          <description>Placebo patch for 15-day quit period
Placebo Patch: Placebo patch</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Any nonserious adverse event</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="64"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="64"/>
              </event>
              <event>
                <sub_title>Lucid dreams</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="64"/>
              </event>
              <event>
                <sub_title>Lightheadedness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="64"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="64"/>
              </event>
              <event>
                <sub_title>Increased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="64"/>
              </event>
              <event>
                <sub_title>Hot or sweating</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Sleep disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Itchiness at Patch Site</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="64"/>
              </event>
              <event>
                <sub_title>Redness at patch site</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The modest sample size limited the ability to precisely characterize how the effects of patch type may be modified by tobacco smoker status, gender, personality traits, and individual differences in marijuana use history.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>David G. Gilbert</name_or_title>
      <organization>Southern Illinois University Carbondale</organization>
      <phone>618-453-3527</phone>
      <email>dgilbert@siu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

